Navigation Links
Sequenom Announces Exercise In Full Of Over-Allotment Option And Completion Of Offering Of $130 Million Of 5.00% Convertible Senior Notes
Date:9/17/2012

SAN DIEGO, Sept. 17, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) today announced the completion of its offering of $130.0 million aggregate principal amount of 5.00% Convertible Senior Notes due 2017 (the "Convertible Notes") in a private offering, including $20.0 million aggregate principal amount of notes sold pursuant to the full exercise of an over-allotment option previously granted to the initial purchasers.  

Sequenom intends to use the net proceeds from this offering to fund the commercialization of the MaterniT21 PLUS laboratory-developed test, as well as for other general corporate purposes, which may include research and development expenses, capital expenditures, working capital and general administrative expenses.

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California.

Forward-Looking Statements

Except for the historical information contained herein, the matters set forth in this press release, including statements regarding Sequenom's expectations with respect to its anticipated use of proceeds from the offering, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission, inc
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors
2. Sequenom Completes International Distribution Agreements To Expand Access To MaterniT21 PLUS Prenatal Testing Service
3. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
4. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
5. Merz, Inc. Announces Cynthia Schwalm as Vice President, Neurology
6. Heska Corporation Announces Amendment To Its Odd-Lot Tender Offer
7. Onconome Announces Results Of Blood Test For Colorectal Cancer; Further Trials Underway
8. Valeant Pharmaceuticals Announces Management Change
9. Neuralstem Announces Proposed Public Offering
10. PPCE Announces Strategic Partnership With ECLINSO AG
11. Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013  Aribex, Inc., manufacturer of the newly released ... new color option, black with gray trim, of the ... markets. The popular white with light blue trim Pro ... be available and both models can be purchased from ... http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are adding ...
(Date:5/22/2013)... May 22, 2013 Attorney Advertising -- Bronstein, ... on behalf of purchasers of the securities of ... AMAG -News).  The investigation focuses on whether the ... On May 22, 2013, Shares of ... after the company announced in regulatory filing that ...
(Date:5/22/2013)... and CAESAREA, Israel , May ... , New clinical data presented from the DEFLECT-I study ... Device reduces brain lesion volume during TAVR (Transcatheter Aortic ... Keystone Heart Scientific Advisory Board announces consensus on ... rising regarding the importance and need for cerebral protection ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4
... study published today in the,journal Current Medical ... superior to Cymbalta®,(duloxetine) in the acute treatment ... was at least as efficacious in,long-term treatment. ... reuptake inhibitor - ASRI) to duloxetine (a,serotonin ...
... - Both co-primary endpoints, Wake After Sleep Onset and ... Sleep, were met at both doses - Evotec to ... 10am EST) today , HAMBURG, Germany | OXFORD, England, ... today positive top-line,results from its first phase II clinical ...
Cached Medicine Technology:Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 2Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4
(Date:5/23/2013)... Platinum Supplemental Insurance recently promoted Mary ... started her Platinum sales career in 2011. Her commitment ... of sales representatives selling Platinum products. , Platinum markets ... of rural communities. Satterlee is in charge of a ... help farmers prepare for the future in the event ...
(Date:5/23/2013)... Francisco, CA (PRWEB) May 23, 2013 ... safety outreach program being tackled by the Safe Passage ... second Fullpower personal safety workshop for women ... and teaches personal safety skills programs for people of ... telling us their experiences with street harassment for years,” ...
(Date:5/23/2013)... May 23, 2013 Fresh Healthy Vending ... machines stocked with healthy food and drinks in locations ... company’s in-house, full-service marketing and advertising department has a ... the media for their franchisees, and to promote the ... been featured in many leading publications and TV networks ...
(Date:5/23/2013)... 2013 Registered Dietitian and Founder of ... today on Tatalou.com offering helpful tips for travelers who ... titled “ How to Stay Healthy While Traveling ,” ... sanitizer, when it’s safe to drink the water when ... importance of staying hydrated and how taking health supplements ...
(Date:5/23/2013)... May 23, 2013 Teen birth rates declined ... to new data released today by the CDC’s ... teen birth rate dropped at least 15% in 48 states ... There were also dramatic declines among all racial/ethnic groups as ...     Birth rates declined 40% or more for Hispanic teens in ...
Breaking Medicine News(10 mins):Health News:Platinum Supplemental Insurance Promotes Mary Satterlee to Sales Team Leader 2Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 2Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 3Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 4Health News:Fresh Healthy Vending Receives Recent National and Local Media Focus 2Health News:How to Stay Healthy While Traveling 2
... Bradford, from Oswestry, a patient with breast cancer in England ... are given free drug treatment// at a hospital. Local health ... the Shropshire Primary Care Trust. The patients in Shropshire have ... protest at the hospital on Monday. ,North Shropshire ...
... London, the cause of autism may now be explained due t ... not interacting well with other people. Weak links between brain areas ... situations as well as other people. ,The study ... an Autism Spectrum Disorder (ASD) while the other 16 did not. ...
... NHS trust failed to adequately supervise two doctors. Amit ... Hospital. It led to the death of the patient ... surgery. He suffered toxic shock syndrome. The hospital ... house officers. ,At a sentencing hearing at ...
... According to a new study of women with early stage, ... disease have been identified that may influence how patients are ... patients from 1988 to 2002 was reviewed by Cancer Research ... are risk factors for invasive disease and the pattern of ...
... Office (NHSO) has found that women aged above 35 are ... should annually undergo a Pap smear test for early detection ... is the most common type of cancer among women. ... scheme, has provided Pap smear services to 1.5 million women ...
... heart's largest artery, the aorta. Studies were going on to ... Johns Hopkins University// have successfully come up with the treatment. ... in recent studies for treating the genetic disorder. The ... appears to prevent the weakening of the heart's largest artery, ...
Cached Medicine News:Health News:Cancer Patients Protest For Free Drug Treatment 2Health News:Lack Of Communication Between Brain Areas Can Cause Autism 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: